A Prolyl endopeptidase-lnhibiting antioxidant fromPhyllanthus ussurensis

Archives of Pharmacal Research

Volumn 26, Issue 12, 2003, Pages 1024-1028

  Chung, Shin Kyo ^a   Nam, Ji Ae ^b   Jeon, So Young ^b   Kim, Sang In ^b   Lee, Hee Ju ^b   Chung, Tai Ho ^c   Song, Kyung Sik ^b  

^a Department of Food Technology ^*  (South Korea)

^b Kyungpook National University   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

Author keywords

Alzheimer; Antioxidant; Corilagin; Inhibitor; Phyllanthus ussurensis; Prolyl endopeptidase

Indexed keywords

ANTIOXIDANT; PLANT EXTRACT; PROLYL ENDOPEPTIDASE; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR;

ARTICLE; CHEMISTRY; DOSE RESPONSE; ISOLATION AND PURIFICATION; METABOLISM; PHYLLANTHUS; PLANT;

ANTIOXIDANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; PHYLLANTHUS; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS;

EID: 4143126486     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/BF02994753     Document Type: Article

References (32)

1. Aoyagi, T., Nagai, M., Ogawa, K., Kojima, F., Okada, M., Ikeda, T., Hamada, M., and Takeuchi, T., Poststatin, a new inhibitor of prolyl endopeptidase produced byStreptomyces viridochromogenes MH534-30F3. I. Taxonomy, production, isolation, physico-chemical properties and biological activities.J. Antibiotics, 44, 949–955 (2002).
2. Aoyagi, T., Wada, T., Nagai, M., Kojima, R., Harada, S., Takeuchi, T., Takahashi, H., Hirokawa, K., and Tsumita, T., Deficiency of kallikrein-like enzyme activities in cerebral tissue of patients with Alzheimer’s disease.Expenentia, 46, 94–97 (1990). DOI: 10.1007/BF01955428
3. Arai, H., Nishioka, H., Niwa, S., Yamanaka, T., Tanaka, Y., Yoshinaga, K., Kobayashi, N., Miura, N., and Ikeda, Y., Synthesis of prolyl endopeptidase inhibitors and evaluation of their structure-activity relationships.In vitro inhibition of prolyl endopeptidase from canine brain.Chem. Pharm. Bull., 41, 1583–1588 (1993).
4. Bakker, A. V., Jung, S., Spencer, R. W., Vinick, F. J., and Faraci, W. S., Slow tight-binding of prolyl endopeptidase by benzyloxycarbonyl-prolyl-prolinal.Biochem. J., 271, 559–562 (1990).
5. Blois, M. S., Antioxidant determination by the use of a stable free radical.Nature, 181, 1199–1201 (1958). DOI: 10.1038/1811199a0
6. Checler, F., Processing of the beta-amyloid precursor protein and its regulation in Alzheimer’s disease.J. Neurochem., 65, 1431–1444 (1995). DOI: 10.1046/j.1471-4159.1995.65041431.x
7. Chung, S. K., Osawa, T., and Kawakishi, S., Hydroxyl radicalscavenging effect of spices and scavengers from brown mustard (Brassica nigra).Biosci. Biotech. Biochem., 61, 118–124 (1997). DOI: 10.1271/bbb.61.118
8. Fan, W., Tezuka, Y., Komatsu, K., Namaba, T., and Kadota, S., Prolyl endopeptidase inhibitors from the underground part o.Rhodiola sacra S. H. Fu.Biol. Pharm. Bull., 22, 157–161 (1999).
9. Glenner, G. G. and Wong, C. W., Alzheimers disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.Biochem. Biophys. Res. Commun., 120, 885–890 (1984). DOI: 10.1016/S0006-291X(84)80190-4
10. Ham, I., Wang, T., Cho, E.-S., Cho, H.-K., and Whang, W.-K., Phenolic compounds fro.Phyllanthus ussuriensis.Yakhak Hoeji, 45, 237–244 (2001).
11. Hwang, J.-S., Song, K.-S., Kim, W.-G., Lee, T.-H., Koshino, H., and Yoo, I.-D., Polyozellin, a new inhibitor of prolyl endope- ptidase fromPolyozellus multiplex.J. Antibiotics, 50, 773–777 (1997).
12. lio, M., Moriyama, A., Matsumoto, Y., Takai, N., and Fukumoto, M., Inhibition of xanthine oxidase by flavonoids.Agric. Biol. Chem., 49, 2173–2182 (1985).
13. Ishiura, S., Tsukahara, T., Tabira, T., Shimizu, T., Arahata, and Sugita, H., Identification of a putative amyloid A4-generating enzyme as a prolyl endopeptidase.FEBS, 260, 131–134 (1990). DOI: 10.1016/0014-5793(90)80084-V
14. Kim, S.-l. and Song, K.-S., 1, 2,3,4,6-Pentagalloyl-(3-D-gluco-pyranose, a prolyl endopeptidase inhibitor from Moutan cortex.J. Korean Soc. Agric. Chem. Biotechnol., 43, 158–161 (2000).
15. Kimura, K., Kawaguchi, N., Yoshihama, M., and Kawanishi, G., Staurosporine, a prolyl endopeptidase inhibitor.Agric. Biol. Chem., 54, 3021–3022 (1990).
16. Kwak, J.-Y., Rhee, I.-K., Lee, K.-B., Hwang, J.-S., Yoo, I.-D., and Song, K.-S., Thelephoric acid and kynapcin-9 from mushroo.Polyozellus multiplex inhibit prolyl endopeptidasein vitro.J. Microbiol. & Biotechnol., 9, 798–803 (1999).
17. Lee, H.-J., Rhee, I.-K., Lee, K.-B., Yoo, I.-D., and Song, K.-S., Kynapcin-12, a new p-terphenyl derivative fromPolyozellus multiplex, inhibits prolyl endopeptidase.J. Antibiotics, 53, 714–719 (2000).
18. Lee, K.-H., Kwak, J.-H., Lee, K.-B., and Song, K.-S., Prolyl endopeptidase inhibitors from Caryophylli Flos.Arch. Pharm. Res., 21, 207–211 (1998). DOI: 10.1007/BF02974029
19. Liu, Y., Qin, L., Wilson, B., An, L., Hong, J.-S., and Liu, B., Inhibition by naloxone stereoisomers of (β-amyloid peptide (1–42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons.J. Pharmacol. & Exp. Therap., 320, 1212–1219 (2002). DOI: 10.1124/jpet.102.035956
20. Mattson, M. P., Involvement of superoxide in pathogenic action of mutations that cause Alzheimer’s disease.Methods in Enzymology, 352 (Redox Cell Biology and Genetics, Part A), 455–474 (2002). DOI: 10.1016/S0076-6879(02)52040-1
21. 2+ homeostasis in Alzheimer’s disease.Trends Neurosci., 16, 409–414 (1993). DOI: 10.1016/0166-2236(93)90009-B
22. Müller, H. E., Detection of hydrogen peroxide produced by microorganism on ABTS-peroxidase medium.Zentralbl Bakteriol. Mikrobio. Hyg., 259, 151–158 (1985).
23. Portevin, B., Benoist, A., Remond, G., Herve, Y., Vincent, M., Lepagnol, J., and De Nanteuil, G., New prolyl endopeptidase inhibitors.In vitro and in vivo activities of azabicyclo[2.2.2] octane, azabicyclo[2.2.1]heptane, and perhydroindole derivatives.J. Med. Chem., 39, 2379–2391 (1996). DOI: 10.1021/jm950858c
24. Prasad, K. N., Hovland, A. R., Cole, W. C., Prasad, K. C., Nahreini, P., Edwards-Prasad, J., and Andreatta, C. P., Multiple antioxidant in the prevention and treatment of Alzheimer disease: analysis of biologic rationale.Clin. Neuropharmacol., 23, 2–13 (2000). DOI: 10.1097/00002826-200001000-00002
25. Qin, L., Liu, Y., Cooper, C., Liu, B., Wilson, B., and Hong, J.-S., Microglia enhance (β-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species.J. Neurochemistry, 83, 973–983 (2002). DOI: 10.1046/j.1471-4159.2002.01210.x
26. Rennex, D., Hemmings, B. A., Hofsteenge, J., and Stone, S. R., cDNA cloning of porcine brain prolyl endopeptidase and identification of the active-site seryl residue.Biochemistry, 30, 2195–2203 (1991). DOI: 10.1021/bi00222a025
27. Sisodia, S. S. and Price, D. L., Role of the β-amyloid protein in Alzheimers disease.FASEB J., 9, 366–370 (1995).
28. Song, K.-S. and Raskin, I., A prolyl endopeptidase-inhibiting benzofuran dimer fro.Polyozellus multiplex.J. Nat. Prod., 65, 76–78 (2002). DOI: 10.1021/np010194b
29. Toda, S., Obi, Y., Numata, K., Hamagishi, Y., Tomita, K., Komiyama, N., Kotake, C., Furumai, T., and Oki, T., Eurystatins A and B, new prolyl endopeptidase inhibitors. I. taxonomy, production, isolation and biological activities.J. Antibiotics, 45, 1573–1579 (1992).
30. Yaron, A. and Naider, F., Proline-dependent structural and biological properties of peptides and proteins.Critic. Rev. Biochem. Mol. Biol., 28, 31–81, (1993). DOI: 10.3109/10409239309082572
31. Yoshimoto, T., Kado, K., Matsubara, F., Koriyama, N., Kaneto, H., and Tsuru, D., Specific inhibitors for prolyl endopeptidase and their anti-amnesic effect.J. Pharmacobio-Dyn. 10, 730–735 (1987).
32. Yoshimoto, T., Nishimura, T., Kita, T., and Tsuru, D., Post-proline cleaving enzyme (prolyl endopeptidase) from bovine brain.J. Biochem., 94, 1179–1190 (1983).